Maxigen Biotech Inc. (TPE:1783)

Market Cap	3.95B
Revenue (ttm)	730.77M
Net Income (ttm)	208.84M
Shares Out	89.68M
EPS (ttm)	2.32
PE Ratio	19.00
Forward PE	n/a
Dividend	0.83 (1.89%)
Ex-Dividend Date	n/a

Volume	81,512
Average Volume	60,526
Open	45.00
Previous Close	43.80
Day's Range	43.05 - 45.00
52-Week Range	35.55 - 55.00
Beta	0.17
RSI	53.67
Earnings Date	Jul 30, 2025

About Maxigen Biotech

Maxigen Biotech Inc. researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally. It operates through two segments, Biomedical Products and Consumer Products. The company offers biomedical materials, such as collagen and bone materials; beauty care products; and medical devices for ophthalmology, otolaryngology, dental, surgical, orthopedics, and medical aesthetics, as well as engages in collagen purification activities. It also provides ophthalmic vis...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1783

Financial Performance

In 2024, Maxigen Biotech's revenue was 680.65 million, an increase of 9.41% compared to the previous year's 622.12 million. Earnings were 190.17 million, an increase of 14.68%.